The global Microfluidics Market was valued at USD 41.9 billion in 2025 and is projected to grow from USD 46.9 billion in 2026 to USD 105.1 billion by 2033, registering a CAGR of 12.2% from 2026 to 2033. North America accounted for the largest revenue share of 42.8% in 2025, driven by the rapid adoption of microfluidic technologies across diagnostics, biomedical research, drug...

The organ-on-a-chip market is gaining traction, with its share expanding significantly due to advancements in biomedical engineering and increased demand for more accurate drug testing models. These microfluidic devices replicate human organ functions, providing a more reliable alternative to traditional cell culture and animal testing methods. With the global healthcare sector emphasizing...